The United Kingdom is witnessing a growing surge in interest surrounding mind-altering substances. Beyond the well-established use of psilocybin and LSD, researchers and adventurers are increasingly delving into less-charted areas, particularly copyright and the budding cannabinoid, CBG. This burgeoning community encompasses clinical trials into em